Tyra Biosciences Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ null, null, 8.3, 54.28, 228.42 ], "ebit_estimate": [ -176.27, -204.24, -221.2, -189.43, -111.45 ], "ebitda_estimate": [ -177.03, -177.54, -174.76, null, null ], "net_income_estimate": [ -164.45, -191.11, -210.05, -223.75, -100.7 ], "per_share_eps_estimate": [ -2.59, -2.84, -3.02, -2.96, -1.4 ], "eps_nri_estimate": [ -2.61, -2.84, -2.99, -2.96, -1.4 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 2.23, 2.89, null, null, null ], "pretax_income_estimate": [ -166.83, -194.04, -213.53, -174.87, -23.86 ], "operating_cash_flow_per_share_estimate": [ -2.19, -2.24, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ -61.78, -110.5, null, null, null ], "gross_margin_estimate": [ 85, 85, 92.5, 86.5, 87 ], "operating_cash_flow_estimate": [ -135.22, -138.31, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": -13.6, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": -14.04, "future_eps_nri_estimate_growth": -13.6, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -18.28, "future_ebitda_estimate_growth": -8.76, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -20.1, "future_pretax_income_estimate_growth": -20.7, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ null, null, null, null, null, null, null, null ], "ebit_estimate": [ -42.94, -44.45, -47.24, -48.27, -50.68, -53.38, -55.89, null ], "ebitda_estimate": [ -43.68, -45.02, -46.31, null, null, null, null, null ], "net_income_estimate": [ -40.43, -41.95, -44.95, -46.34, -48.74, -51.42, -53.89, null ], "per_share_eps_estimate": [ -0.64, -0.64, -0.67, -0.7, -0.72, -0.76, -0.82, null ], "eps_nri_estimate": [ -0.65, -0.65, -0.67, -0.71, -0.73, -0.77, -0.82, -0.84 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -40.42, -42, -45.14, -46.34, -48.74, -51.42, -53.89, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null, null ], "long_term_growth_rate_mean": -13.6, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": -14.04, "future_eps_nri_estimate_growth": -13.6, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -18.28, "future_ebitda_estimate_growth": -8.76, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -20.1, "future_pretax_income_estimate_growth": -20.7, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }